SCHEMBL26388371

SCHEMBL26388371

COCc1nn(C)cc1I

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15884785 0.81 IRAK4 (0.32) —
SCHEMBL12970567 0.79 — —
SCHEMBL26388323 0.77 — —
SCHEMBL26030617 0.76 — —
SCHEMBL15884297 0.76 SMN1; SMN2 (0.33) —
SCHEMBL2184630 0.76 KDM4E (0.35) —
SCHEMBL17247576 0.73 USP2 (0.31) —
SCHEMBL17786799 0.73 GAA (0.40) —
SCHEMBL10665972 0.73 GAA (0.40) —
Hydrochloric Acid SCHEMBL10665980 0.72 GAA (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192901-A9 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-14 — — WO disclosed
WO-2023192901-A1 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-10-05 — — WO disclosed
Send feedback